Marco Vignetti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Health-Related Quality of Life of Patients with Philadelphia-Negative Myeloproliferative Neoplasms Compared with the General Population: A Preliminary Report from the Gimema Prophecy Study	BLOOD	2022
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study	THE LANCET. HEALTHY LONGEVITY	2022
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study	THE LANCET. HEALTHY LONGEVITY	2022
A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients. Final results of the GIMEMA LAL1509 protocol	HAEMATOLOGICA	2021
Clinical utility and physician perceptions of a digital platform for electronic patient-reported outcomes monitoring in patients with hematologic malignancies in real-world practice.	BLOOD	2021
Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors	BMJ SUPPORTIVE & PALLIATIVE CARE	2021
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study	BLOOD	2021
Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab	BLOOD	2021
Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2021
Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996	AMERICAN JOURNAL OF HEMATOLOGY	2021
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial	AMERICAN JOURNAL OF HEMATOLOGY	2021
Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia	LEUKEMIA & LYMPHOMA	2021
Optimizing health-related quality of life in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors	EXPERT REVIEW OF HEMATOLOGY	2021
Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2021
The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L	JOURNAL OF CLINICAL EPIDEMIOLOGY	2021
The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study	JMIR RESEARCH PROTOCOLS	2021
Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature review	EXPERT REVIEW OF HEMATOLOGY	2021
Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy	BLOOD ADVANCES	2021
High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)	HAEMATOLOGICA	2020
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity	INTERNATIONAL JOURNAL OF HEMATOLOGY	2020